Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures

Reaction to Avandia warnings stronger among internists than endocrinologists, according to study by GfK Market Measures. (Graphic: Business Wire)

View Full Size

Download

Thumbnail JPEG, 72x49, 2.3 KB
Preview JPEG, 144x98, 5.6 KB
Small JPEG, 300x206, 19.7 KB
Full Size JPEG, 600x412, 57.7 KB

Smart Multimedia Gallery

Reaction to Avandia warnings stronger among internists than endocrinologists, according to study by GfK Market Measures. (Graphic: Business Wire)

Internists will switch more than half their patients currently on Avandia to another therapy, following the published NEJM warnings about Avandia, according to study by GfK Market Measures. (Graphic: Business Wire)

View and Share Graphic

http://www.businesswire.com/multimedia/google/20070711005284/en/1477269/Reaction-Avandia-Warnings-Stronger-Internists-Endocrinologists-Study

View and Share Logo

All News | News with Multimedia > News Release: Reaction to Avandia Warnings Stronger Among Int...

Get Business Wire News on Your Website

Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures

Download

Smart Multimedia Gallery

View and Share Graphic

View and Share Logo

Share

Better Be Business Wired.